Prevention of mycosis in granulocytopenic patients with prophylactic ketoconazole treatment.
D000208:Acute Disease; D000328:Adult; D000380:Agranulocytosis / Q000150:complications*; D000935:Antifungal Agents / Q000627:therapeutic use*; D002179:Candidiasis, Cutaneous / Q000517:prevention & control*; D004311:Double-Blind Method; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D007654:Ketoconazole; D007938:Leukemia / Q000150:complications; D010879:Piperazines / Q000627:therapeutic use*
D000935:Antifungal Agents; D007093:Imidazoles; D010879:Piperazines; D007654:Ketoconazole